Binex Co., a bio-CDMO in the Asian-Pacific region, has purchased a Gyrolab workstation. The Gyros platform is used by biopharma companies and service providers to improve productivity and efficiency during the development of biotherapeutics and vaccines. The platform comprises a Gyrolab workstation, control and evaluation software and the microfluidic CDs in which immunoassay steps are integrated and run at nanoliter scale.
 
Erik Walldén, chief executive officer at Gyros, said, “We have been actively expanding our distributor network throughout the Asia-Pacific region and see this as a significant step on the way to establishing a global presence for our immunoassay platform.”